A friend of mine remarked the other day, wearing a pained expression, that he wished he had bought Dogecoin. “What? Why?” I asked, struggling to mask my incredulity. “Because the price has gone up so much. It’s up, like, 1,000% recently,” he said. “Elon Musk is endorsing it.” (Dogecoin’s price has surged 1,600% since the […]
Very good day, readers. We’ve written widely concerning the emerging therapeutics from the coronavirus. Among the first contenders has been remdesivir, an antifungal from biotech giant Gilead. It’s no save-all; however, it did only score a coveted difference as the very first Food and Drug Administration (FDA) accepted treatment to handle COVID-19. Up till this […]
The progress is due to booster shots and newly eligible 5-11 year-olds—and vaccine mandates. Read More
